GAB2 is a novel target of 11q amplification in AML/MDS

Genes Chromosomes and Cancer

Volumn 45, Issue 9, 2006, Pages 798-807

  Zatkova, Andrea ^a,d   Schoch, Claudia ^b   Speleman, Frank ^c   Poppe, Bruce ^c   Mannhalter, Christine ^a   Fonatsch, Christa ^a   Wimmer, Katharina ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MLL MUNICH LEUKEMIA LABORATORY   (Germany)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; GRB2 ASSOCIATED BINDING PROTEIN 2; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN GAB2; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHROMOSOME 11Q; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE LOCUS; HUMAN; MALE; MLL GENE; MYELODYSPLASTIC SYNDROME; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RARE DISEASE; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; GENE AMPLIFICATION; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES;

EID: 33746830104     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20344     Document Type: Article

References (37)

1. Andersen MK, Christiansen DH, Kirchhoff M, Pedersen-Bjergaard J. 2001. Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents. Genes Chromosomes Cancer 31:33-41.
2. Bentires-Alj M, Gil SG, Chan R, Wang ZC, Wang Y, Imanaka N, Harris LN, Richardson A, Neel BG, Gu H. 2006. A role for the scaffolding adapter GAB2 in breast cancer. Nat Med 12:114-121.
3. Bernard OA, Berger R. 1995. Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes Chromosomes Cancer 13:75-85.
4. Chaussepied M, Ginsberg D. 2004. Transcriptional regulation of AKT activation by E2F. Mol Cell 16:831-837.
5. Cuthbert G, Thompson K, McCullough S, Watmore A, Dickinson H, Telford N, Mugneret F, Harrison C, Griffiths M, Bown N. 2000. MLL amplification in acute leukaemia: A United Kingdom Cancer Cytogenetics Group (UKCCG) study. Leukemia 14:1885-1891.
6. Daly RJ, Gu H, Parmar J, Malaney S, Lyons RJ, Kairouz R, Head DR, Henshall SM, Neel BG, Sutherland RL. 2002. The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer. Oncogene 21:5175-5181.
7. Dorsey JF, Cunnick JM, Mane SM, Wu J. 2002. Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Ab1(+) K562 leukemic cells by Gab2. Blood 99:1388-1397.
8. Fonatsch C, Streubel B. 1998. Classical and molecular cytogenetics. In: Huhn D, editor. New Diagnostic Methods in Oncology and Hematology. Berlin: Springer-Verlag, pp. 113-141.
9. Gu H, Pratt JC, Burakoff SJ, Neel BG. 1998. Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Mol Cell 2:729-740.
10. Heemers H, Vanderhoydonc F, Heyns W, Verhoeven G, Swinnen JV. 2000. Progestins and androgens increase expression of Spot 14 in T47-D breast tumor cells. Biochem Biophys Res Commun 269:209-212.
11. Ischenko I, Petrenko O, Gu H, Hayman MJ. 2003. Scaffolding protein Gab2 mediates fibroblast transformation by the SEA tyrosine kinase. Oncogene 22:6311-6318.
12. Kakazu N, Taniwaki M, Horiike S, Nishida K, Tatekawa T, Nagai M, Takahashi T, Akaogi T, Inazawa J, Ohki M, Abe T. 1999. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome. Genes Chromosomes Cancer 26:336-345.
13. Kim MH, Stewart J, Devlin C, Kim YT, Boyd E, Connor M. 2001. The application of comparative genomic hybridization as an additional tool in the chromosome analysis of acute myeloid leukemia and myelodysplastic syndromes. Cancer Genet Cytogenet 126:26-33.
14. Lee AS, Lie DK, Tien SL, Rudduck-Sivaswaren C. 2004. Increased amplification proximal to the MLL gene in acute myeloid leukemia. Int J Mol Med 13:63-67.
15. Lindvall C, Nordenskjold M, Porwit A, Bjorkholm M, Blennow E. 2001. Molecular cytogenetic characterization of acute myeloid leukemia and myelodysplastic syndromes with multiple chromosome rearrangements. Haematologica 86:1158-1164.
16. Martinez-Ramirez A, Urioste M, Alvarez S, Vizmanos JL, Calasanz MJ, Cigudosa JC, Benitez J. 2004. Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: An analysis using spectral karyotyping. Cancer Genet Cytogenet 153:39-47.
17. Martinez-Ramirez A, Urioste M, Melchor L, Blesa D, Valle L, de Andres SA, Kok K, Calasanz MJ, Cigudosa JC, Benitez J. 2005. Analysis of myelodysplastic syndromes with complex karyo-types by high-resolution comparative genomic hybridization and subtelomeric CGH array. Genes Chromosomes Cancer 42:287-298.
18. Michaux L, Wlodarska I, Stul M, Dierlamm J, Mugneret F, Herens C, Beverloo B, Verhest A, Verellen-Dumoulin C, Verhoef G, Selleslag D, Madoe V, Lecomte M, Deprijck B, Ferrant A, Delannoy A, Marichal S, Duhem C, Dicato M, Hagemeijer A. 2000. MLL amplification in myeloid leukemias: A study of 14 cases with multiple copies of 11q23. Genes Chromosomes Cancer 29:40-47.
19. Mohi MG, Williams IR, Dearolf CR, Chan G, Kutok JL, Cohen S, Morgan K, Boulton C, Shigematsu H, Keilhack H, Akashi K, Gilliland DG, Neel BG. 2005. Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell 7:179-191.
20. Mrozek K, Heinonen K, Theil KS, Bloomfield CD. 2002. Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q. Genes Chromosomes Cancer 34:137-153.
21. Nishida K, Hirano T. 2003. The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors. Cancer Sci 94:1029-1033.
22. Papenhausen PR, Griffin S, Tepperberg J. 2005. Oncogene amplification in transforming myelodysplasia. Exp Mol Pathol 79:168-175.
23. Pattyn F, Speleman F, De Paepe A, Vandesompele J. 2003. RTPrimerDB: The real-time PCR primer and probe database. Nucleic Acids Res 31:122-123.
24. Podar K, Mostoslavsky G, Sattler M, Tai YT, Hayashi T, Catley LP, Hideshima T, Mulligan RC, Chauhan D, Anderson KC. 2004. Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells. J Biol Chem 279:21658-21665.
25. Poppe B, Vandesompele J, Schoch C, Lindvall C, Mrozek K, Bloomfield CD, Beverloo HB, Michaux L, Dastugue N, Herens C, Yigit N, De Paepe A, Hagemeijer A, Speleman F. 2004. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Blood 103:229-235.
26. Quesada V, Diaz-Perales A, Gutierrez-Fernandez A, Garabaya C, Cal S, Lopex-Otin C. 2004. Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. Biochem Biophys Res Commun 314:54-62.
27. Sarmay G, Angyal A, Kertesz A, Maus M, Medgyesi D. 2005. The multiple funetion of Grb2 associated binder (Gab) adaptor/scaf-folding protein in immune cell signaling. Immunol Lett 104:76-82.
28. Sattler M, Mohi MG, Pride YB, Quinnan LR, Malouf NA, Podar K, Gesbert F, Iwasaki H, Li S, Van Etten RA, Gu H, Griffin JD, Neel BG. 2002. Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell 1:479-492.
29. Schraml P, Schwerdtfeger G, Burkhalter F, Raggi A, Schmidt D, Ruffalo T, King W, Wilber K, Mihatseh MJ, Moch H. 2003. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol 163:985-992.
30. Smith A, Heaps LS, Sharma P, Jarvis A, Forsyth C. 2001. Abnormal dicentric chromosome with co-amplification of sequences from chromosomes 11 and 19: A novel rearrangement in a patient with myelodysplastic syndrome transforming to acute myeloid leukemia. Cancer Genet Cytogenet 130:29-32.
31. Streubel B, Valent P, Jager U, Edelhauser M, Wandt H, Wagner T, Buchner T, Lechner K, Fonatsch C. 2000. Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome. Genes Chromosomes Cancer 27:380-386.
32. Tyybakinoja A, Saarinen-Pihkala LI, Elonen E, Knuutila S. 2006. Amplified, lost, and fused genes in 11q23-25 amplicon in acute myeloid leukemia, an array-CGH study. Genes Chromosomes Cancer 45:257-264.
33. Van Limbergen H, Poppe B, Michaux L, Herens C, Brown J, Noens L, Berneman Z, De Bock R, De Paepe A, Speleman F. 2002. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH. Genes Chromosomes Cancer 33:60-72.
34. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034.
35. Zatkova A, Rouillard JM, Hartmann W, Lamb BJ, Kuick R, Eckart M, von Schweinitz D, Koch A, Fonatseh C, Pietsch T, Hanash SM, Wimmer K. 2004. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma. Genes Chromosomes Cancer 39:126-137.
36. Zatkova A, Ullmann R, Rouillard JM, Lamb BJ, Kuick R, Hanash SM, Schnittger S, Sehoch C, Fonatsch C, Wimmer K. 2004. Distinct sequences on 11q135 and 11q23-24 are frequently coamplified with MLL in complexly organized 11q amplicons in AML/MDS patients. Genes Chromosomes Cancer 39:263-276.
37. Zhu QS, Robinson LJ, Roginskaya V, Corey SJ. 2004. G-CSF-induced tyrosine phosphorylation of Gab2 is Lyn kinase dependent and associated with enhanced Akt and differentiative, not proliferative, responses. Blood 103:3305-3312.